News
A dated archive of the posts published on the official site. Items are historical; each links to the original announcement.
22 announcements
Annual update reporting dermatitis biopsy work, a formulation collaboration, exploratory JEL3108 work on lung cancer cells and the portfolio grouping.
Read original announcement ↗ (opens in a new tab)
The company reports its selection among four winners of the inaugural Boston Bootcamp. The article’s header and body dates differ.
Read original announcement ↗ (opens in a new tab)
The CEO presents the company at BioSeed 2024.
Read original announcement ↗ (opens in a new tab)
Release of a new corporate video.
Read original announcement ↗ (opens in a new tab)
The company reports JEL0305 effects in eczema and burn biopsy tissue (preclinical). The body dateline reads January 2022.
Read original announcement ↗ (opens in a new tab)
Announcement of a further US$500,000 (£404,000) from Deepbridge for preclinical skin studies.
Read original announcement ↗ (opens in a new tab)
The company presents at the BIO International Convention 2022 in San Diego.
Read original announcement ↗ (opens in a new tab)
Selection as a finalist for the RESI Innovator’s Pitch Challenge.
Read original announcement ↗ (opens in a new tab)
HRA/HCRW and favourable REC permission announced for ex vivo research on burns and reconstruction tissue with an Oxford clinical researcher. This concerns tissue research, not a medicine approval.
Read original announcement ↗ (opens in a new tab)
A company article on its anti-inflammation approach to scarring.
Read original announcement ↗ (opens in a new tab)
The company presents at a CONNECTpreneur investor event.
Read original announcement ↗ (opens in a new tab)
The company speaks at the 2022 BIO CEO & Investor Conference.
Read original announcement ↗ (opens in a new tab)
Approximately £100,000 additional Innovate UK grant reported for preclinical burns work.
Read original announcement ↗ (opens in a new tab)
Additional £150,000 Deepbridge investment reported after company preclinical work.
Read original announcement ↗ (opens in a new tab)
Innovate UK Smart grant reported for preclinical anti-inflammatory burns research.
Read original announcement ↗ (opens in a new tab)£250,000 Deepbridge seed investment reported.
Read original announcement ↗ (opens in a new tab)
Participation in BioSeed 2020.
Read original announcement ↗ (opens in a new tab)
Participation around the J.P. Morgan Healthcare Conference.
Read original announcement ↗ (opens in a new tab)
Participation in BioEurope 2019.
Read original announcement ↗ (opens in a new tab)
Participation in the Investival Showcase 2019.
Read original announcement ↗ (opens in a new tab)Bridge Biotec announces its new name, Carocell Bio.
Read original announcement ↗ (opens in a new tab)Participation in the BIO International Convention 2019.
Read original announcement ↗ (opens in a new tab)Funding figures are historical announcements; they are not summed and do not represent a current financing round.